NCT07253220 2025-11-28
TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma
Sun Yat-sen University
Phase NA Not yet recruiting
Clinical Trials
27 trialsNCT06084234 2025-11-26
TRACER
University of Texas Southwestern Medical Center
Phase 4 Recruiting
NCT07038863 2025-06-26
Mondelta
Hospices Civils de Lyon
Phase NA Not yet recruiting
NCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT04000737 2025-04-13
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Yiviva Inc.
Phase 2 Completed
NCT05195294 2025-03-10
Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC
Lion TCR Pte. Ltd.
Phase 2 Not yet recruiting
NCT04710641 2025-03-06
OUTREACH2
Mina Alpha Limited
Phase 2 Completed
NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT05304234 2024-06-04
Liver Cancer Disparities in American Indian and Alaska Native Persons
University of Washington
Phase 2 Recruiting
NCT04659005 2022-04-06
Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening
Chinese University of Hong Kong
Phase NA Completed
NCT04317248 2020-10-29
"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University
Phase 2 Unknown
NCT04044651 2020-01-09
Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection
Sun Yat-sen University
Phase 2/3 Withdrawn
NCT04032392 2019-07-25
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells
Beijing 302 Hospital
Phase 1 Unknown
NCT00888407 2017-05-30
Community-based Hepatitis B Interventions for Hmong Adults
University of California, Davis
Phase NA Completed
NCT00322361 2017-03-16
Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT01790633 2016-12-13
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase NA Completed
NCT02779465 2016-05-20
VDHCC
Third Affiliated Hospital, Sun Yat-Sen University
Phase 4 Not yet recruiting
NCT00824707 2016-04-01
Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT00834158 2016-04-01
TACEPVE
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT01872988 2014-09-04
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma
Taichung Veterans General Hospital
Phase 3 Terminated
NCT01022476 2013-07-18
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2 Completed
NCT00629486 2013-04-18
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase NA Completed
NCT00822991 2010-12-30
Sonazoid Enhanced Liver Cancer Trial for Early Detection
Kindai University
Phase NA Unknown
NCT01102335 2010-04-13
TACEHBV
Fudan University
Phase 4 Unknown
NCT00960518 2009-08-17
TACE
Tongji University
Phase 2 Unknown
NCT00768157 2009-02-09
Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
Sun Yat-sen University
Phase 4 Unknown
NCT00222664 2005-09-22
Qidong Hepatitis B Intervention Study
University of Oxford
Phase 4 Completed